Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis June 27, 2018 No Comments
Argenx reports cohort 1 interim data from phase II study of efgartigimod in pemphigus vulgaris June 20, 2018 No Comments
Phase II study of IMO-8400 in dermatomyositis does not meet primary endpoint June 13, 2018 No Comments
RSS